nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—multiple sclerosis	0.353	1	CbGaD
Chloroquine—GSTA2—Azathioprine—multiple sclerosis	0.283	0.591	CbGbCtD
Chloroquine—CYP2D6—Fingolimod—multiple sclerosis	0.0238	0.0497	CbGbCtD
Chloroquine—ABCB1—Methylprednisolone—multiple sclerosis	0.0163	0.034	CbGbCtD
Chloroquine—CYP1A1—Dexamethasone—multiple sclerosis	0.0158	0.0329	CbGbCtD
Chloroquine—CYP3A4—Fingolimod—multiple sclerosis	0.0151	0.0316	CbGbCtD
Chloroquine—ABCB1—Mitoxantrone—multiple sclerosis	0.0119	0.0248	CbGbCtD
Chloroquine—ABCB1—Betamethasone—multiple sclerosis	0.0106	0.0221	CbGbCtD
Chloroquine—ABCB1—Prednisolone—multiple sclerosis	0.0104	0.0218	CbGbCtD
Chloroquine—ABCB1—Prednisone—multiple sclerosis	0.00986	0.0206	CbGbCtD
Chloroquine—CYP3A4—Methylprednisolone—multiple sclerosis	0.00975	0.0204	CbGbCtD
Chloroquine—CYP3A5—Dexamethasone—multiple sclerosis	0.00945	0.0198	CbGbCtD
Chloroquine—CYP2C8—Dexamethasone—multiple sclerosis	0.00909	0.019	CbGbCtD
Chloroquine—CYP3A4—Triamcinolone—multiple sclerosis	0.00739	0.0154	CbGbCtD
Chloroquine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00711	0.0149	CbGbCtD
Chloroquine—CYP3A4—Betamethasone—multiple sclerosis	0.00634	0.0132	CbGbCtD
Chloroquine—CYP3A4—Prednisolone—multiple sclerosis	0.00625	0.0131	CbGbCtD
Chloroquine—ABCB1—Dexamethasone—multiple sclerosis	0.00615	0.0129	CbGbCtD
Chloroquine—CYP3A4—Prednisone—multiple sclerosis	0.00591	0.0123	CbGbCtD
Chloroquine—CYP2D6—Dexamethasone—multiple sclerosis	0.0058	0.0121	CbGbCtD
Chloroquine—ABCB1—Methotrexate—multiple sclerosis	0.00494	0.0103	CbGbCtD
Chloroquine—CYP3A4—Dexamethasone—multiple sclerosis	0.00369	0.00771	CbGbCtD
Chloroquine—Atrophy—Prednisone—multiple sclerosis	0.00101	0.0133	CcSEcCtD
Chloroquine—Reaction gastrointestinal—Methotrexate—multiple sclerosis	0.000822	0.0109	CcSEcCtD
Chloroquine—Aplastic anaemia—Cladribine—multiple sclerosis	0.000786	0.0104	CcSEcCtD
Chloroquine—Alopecia—Fingolimod—multiple sclerosis	0.000656	0.00868	CcSEcCtD
Chloroquine—Myopathy—Prednisolone—multiple sclerosis	0.000644	0.00852	CcSEcCtD
Chloroquine—Aplastic anaemia—Azathioprine—multiple sclerosis	0.000639	0.00846	CcSEcCtD
Chloroquine—Vision blurred—Fingolimod—multiple sclerosis	0.000609	0.00806	CcSEcCtD
Chloroquine—Myopathy—Triamcinolone—multiple sclerosis	0.000592	0.00784	CcSEcCtD
Chloroquine—Myopathy—Methylprednisolone—multiple sclerosis	0.000591	0.00782	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.000547	0.00724	CcSEcCtD
Chloroquine—Myopathy—Dexamethasone—multiple sclerosis	0.000537	0.00711	CcSEcCtD
Chloroquine—Myopathy—Betamethasone—multiple sclerosis	0.000537	0.00711	CcSEcCtD
Chloroquine—Eosinophilia—Cladribine—multiple sclerosis	0.00052	0.00688	CcSEcCtD
Chloroquine—Pancytopenia—Cladribine—multiple sclerosis	0.000499	0.0066	CcSEcCtD
Chloroquine—Hypotension—Fingolimod—multiple sclerosis	0.000492	0.00652	CcSEcCtD
Chloroquine—Neutropenia—Cladribine—multiple sclerosis	0.000491	0.0065	CcSEcCtD
Chloroquine—Cinchocaine—BCHE—multiple sclerosis	0.000486	1	CrCbGaD
Chloroquine—Myopathy—Prednisone—multiple sclerosis	0.000468	0.00619	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.000464	0.00615	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000455	0.00602	CcSEcCtD
Chloroquine—Eruption—Methotrexate—multiple sclerosis	0.000446	0.0059	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.000445	0.00589	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.000413	0.00546	CcSEcCtD
Chloroquine—Pancytopenia—Azathioprine—multiple sclerosis	0.000406	0.00537	CcSEcCtD
Chloroquine—Erythema multiforme—Cladribine—multiple sclerosis	0.000398	0.00526	CcSEcCtD
Chloroquine—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000396	0.00525	CcSEcCtD
Chloroquine—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000396	0.00524	CcSEcCtD
Chloroquine—Delirium—Prednisone—multiple sclerosis	0.000382	0.00505	CcSEcCtD
Chloroquine—Asthenia—Fingolimod—multiple sclerosis	0.000378	0.005	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.000378	0.005	CcSEcCtD
Chloroquine—Pruritus—Fingolimod—multiple sclerosis	0.000373	0.00494	CcSEcCtD
Chloroquine—Alopecia—Cladribine—multiple sclerosis	0.000372	0.00492	CcSEcCtD
Chloroquine—Diarrhoea—Fingolimod—multiple sclerosis	0.000361	0.00477	CcSEcCtD
Chloroquine—Skin exfoliation—Dexamethasone—multiple sclerosis	0.00036	0.00476	CcSEcCtD
Chloroquine—Skin exfoliation—Betamethasone—multiple sclerosis	0.00036	0.00476	CcSEcCtD
Chloroquine—Agranulocytosis—Azathioprine—multiple sclerosis	0.000355	0.0047	CcSEcCtD
Chloroquine—Visual disturbance—Prednisolone—multiple sclerosis	0.000346	0.00458	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000339	0.00448	CcSEcCtD
Chloroquine—Headache—Fingolimod—multiple sclerosis	0.00033	0.00437	CcSEcCtD
Chloroquine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000328	0.00434	CcSEcCtD
Chloroquine—Erythema multiforme—Azathioprine—multiple sclerosis	0.000323	0.00428	CcSEcCtD
Chloroquine—Neutropenia—Mitoxantrone—multiple sclerosis	0.000323	0.00427	CcSEcCtD
Chloroquine—Skin exfoliation—Prednisone—multiple sclerosis	0.000313	0.00415	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000311	0.00412	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000311	0.00411	CcSEcCtD
Chloroquine—Anxiety—Cladribine—multiple sclerosis	0.000311	0.00411	CcSEcCtD
Chloroquine—Alopecia—Azathioprine—multiple sclerosis	0.000302	0.004	CcSEcCtD
Chloroquine—Confusional state—Cladribine—multiple sclerosis	0.000301	0.00399	CcSEcCtD
Chloroquine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000294	0.00389	CcSEcCtD
Chloroquine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000293	0.00387	CcSEcCtD
Chloroquine—Visual disturbance—Dexamethasone—multiple sclerosis	0.000289	0.00382	CcSEcCtD
Chloroquine—Visual disturbance—Betamethasone—multiple sclerosis	0.000289	0.00382	CcSEcCtD
Chloroquine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000287	0.0038	CcSEcCtD
Chloroquine—Anorexia—Cladribine—multiple sclerosis	0.000285	0.00377	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000283	0.00374	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000283	0.00374	CcSEcCtD
Chloroquine—Hypotension—Cladribine—multiple sclerosis	0.000279	0.00369	CcSEcCtD
Chloroquine—Hepatitis—Mitoxantrone—multiple sclerosis	0.000276	0.00366	CcSEcCtD
Chloroquine—Insomnia—Cladribine—multiple sclerosis	0.00027	0.00358	CcSEcCtD
Chloroquine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000267	0.00354	CcSEcCtD
Chloroquine—Psychotic disorder—Betamethasone—multiple sclerosis	0.000267	0.00354	CcSEcCtD
Chloroquine—Skin exfoliation—Methotrexate—multiple sclerosis	0.000262	0.00347	CcSEcCtD
Chloroquine—Decreased appetite—Cladribine—multiple sclerosis	0.00026	0.00344	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000258	0.00341	CcSEcCtD
Chloroquine—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000257	0.00341	CcSEcCtD
Chloroquine—Feeling abnormal—Cladribine—multiple sclerosis	0.000246	0.00326	CcSEcCtD
Chloroquine—Alopecia—Mitoxantrone—multiple sclerosis	0.000244	0.00323	CcSEcCtD
Chloroquine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000238	0.00315	CcSEcCtD
Chloroquine—Urticaria—Cladribine—multiple sclerosis	0.000237	0.00314	CcSEcCtD
Chloroquine—Abdominal pain—Cladribine—multiple sclerosis	0.000236	0.00313	CcSEcCtD
Chloroquine—Psychotic disorder—Prednisone—multiple sclerosis	0.000233	0.00308	CcSEcCtD
Chloroquine—Hypotension—Azathioprine—multiple sclerosis	0.000227	0.003	CcSEcCtD
Chloroquine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000227	0.003	CcSEcCtD
Chloroquine—Photosensitivity—Methotrexate—multiple sclerosis	0.000227	0.003	CcSEcCtD
Chloroquine—Visual impairment—Prednisolone—multiple sclerosis	0.000219	0.00289	CcSEcCtD
Chloroquine—Asthenia—Cladribine—multiple sclerosis	0.000214	0.00284	CcSEcCtD
Chloroquine—Pruritus—Cladribine—multiple sclerosis	0.000211	0.0028	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000211	0.00279	CcSEcCtD
Chloroquine—Visual disturbance—Methotrexate—multiple sclerosis	0.00021	0.00278	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00021	0.00278	CcSEcCtD
Chloroquine—Convulsion—Mitoxantrone—multiple sclerosis	0.000208	0.00276	CcSEcCtD
Chloroquine—Hallucination—Methylprednisolone—multiple sclerosis	0.000207	0.00274	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000206	0.00272	CcSEcCtD
Chloroquine—Diarrhoea—Cladribine—multiple sclerosis	0.000204	0.00271	CcSEcCtD
Chloroquine—Anxiety—Mitoxantrone—multiple sclerosis	0.000204	0.0027	CcSEcCtD
Chloroquine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000201	0.00265	CcSEcCtD
Chloroquine—Feeling abnormal—Azathioprine—multiple sclerosis	0.0002	0.00265	CcSEcCtD
Chloroquine—Confusional state—Mitoxantrone—multiple sclerosis	0.000198	0.00262	CcSEcCtD
Chloroquine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000196	0.0026	CcSEcCtD
Chloroquine—Neutropenia—Prednisone—multiple sclerosis	0.000193	0.00255	CcSEcCtD
Chloroquine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000192	0.00254	CcSEcCtD
Chloroquine—Abdominal pain—Azathioprine—multiple sclerosis	0.000192	0.00254	CcSEcCtD
Chloroquine—Vomiting—Cladribine—multiple sclerosis	0.00019	0.00251	CcSEcCtD
Chloroquine—Rash—Cladribine—multiple sclerosis	0.000188	0.00249	CcSEcCtD
Chloroquine—Hallucination—Betamethasone—multiple sclerosis	0.000188	0.00249	CcSEcCtD
Chloroquine—Hallucination—Dexamethasone—multiple sclerosis	0.000188	0.00249	CcSEcCtD
Chloroquine—Anorexia—Mitoxantrone—multiple sclerosis	0.000187	0.00248	CcSEcCtD
Chloroquine—Headache—Cladribine—multiple sclerosis	0.000187	0.00248	CcSEcCtD
Chloroquine—Vision blurred—Prednisolone—multiple sclerosis	0.000186	0.00246	CcSEcCtD
Chloroquine—Hypotension—Mitoxantrone—multiple sclerosis	0.000183	0.00243	CcSEcCtD
Chloroquine—Visual impairment—Dexamethasone—multiple sclerosis	0.000182	0.00241	CcSEcCtD
Chloroquine—Visual impairment—Betamethasone—multiple sclerosis	0.000182	0.00241	CcSEcCtD
Chloroquine—Angioedema—Prednisolone—multiple sclerosis	0.00018	0.00239	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000179	0.00237	CcSEcCtD
Chloroquine—Nausea—Cladribine—multiple sclerosis	0.000177	0.00235	CcSEcCtD
Chloroquine—Convulsion—Prednisolone—multiple sclerosis	0.000171	0.00226	CcSEcCtD
Chloroquine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000171	0.00226	CcSEcCtD
Chloroquine—Eosinophilia—Methotrexate—multiple sclerosis	0.00017	0.00225	CcSEcCtD
Chloroquine—Alopecia—Dexamethasone—multiple sclerosis	0.000167	0.00221	CcSEcCtD
Chloroquine—Alopecia—Betamethasone—multiple sclerosis	0.000167	0.00221	CcSEcCtD
Chloroquine—Diarrhoea—Azathioprine—multiple sclerosis	0.000166	0.0022	CcSEcCtD
Chloroquine—Angioedema—Triamcinolone—multiple sclerosis	0.000166	0.0022	CcSEcCtD
Chloroquine—Angioedema—Methylprednisolone—multiple sclerosis	0.000166	0.00219	CcSEcCtD
Chloroquine—Hallucination—Prednisone—multiple sclerosis	0.000164	0.00217	CcSEcCtD
Chloroquine—Pancytopenia—Methotrexate—multiple sclerosis	0.000163	0.00216	CcSEcCtD
Chloroquine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000162	0.00214	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000161	0.00213	CcSEcCtD
Chloroquine—Neutropenia—Methotrexate—multiple sclerosis	0.000161	0.00213	CcSEcCtD
Chloroquine—Convulsion—Triamcinolone—multiple sclerosis	0.000157	0.00208	CcSEcCtD
Chloroquine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000157	0.00208	CcSEcCtD
Chloroquine—Convulsion—Methylprednisolone—multiple sclerosis	0.000157	0.00208	CcSEcCtD
Chloroquine—Urticaria—Mitoxantrone—multiple sclerosis	0.000156	0.00206	CcSEcCtD
Chloroquine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000155	0.00205	CcSEcCtD
Chloroquine—Vomiting—Azathioprine—multiple sclerosis	0.000154	0.00204	CcSEcCtD
Chloroquine—Anxiety—Methylprednisolone—multiple sclerosis	0.000154	0.00203	CcSEcCtD
Chloroquine—Rash—Azathioprine—multiple sclerosis	0.000153	0.00203	CcSEcCtD
Chloroquine—Headache—Azathioprine—multiple sclerosis	0.000152	0.00201	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000152	0.00201	CcSEcCtD
Chloroquine—Angioedema—Betamethasone—multiple sclerosis	0.000151	0.00199	CcSEcCtD
Chloroquine—Angioedema—Dexamethasone—multiple sclerosis	0.000151	0.00199	CcSEcCtD
Chloroquine—Confusional state—Methylprednisolone—multiple sclerosis	0.000149	0.00197	CcSEcCtD
Chloroquine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000148	0.00196	CcSEcCtD
Chloroquine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000148	0.00196	CcSEcCtD
Chloroquine—Insomnia—Prednisolone—multiple sclerosis	0.000146	0.00193	CcSEcCtD
Chloroquine—Alopecia—Prednisone—multiple sclerosis	0.000146	0.00193	CcSEcCtD
Chloroquine—Nausea—Azathioprine—multiple sclerosis	0.000144	0.00191	CcSEcCtD
Chloroquine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000143	0.00189	CcSEcCtD
Chloroquine—Convulsion—Dexamethasone—multiple sclerosis	0.000143	0.00189	CcSEcCtD
Chloroquine—Convulsion—Betamethasone—multiple sclerosis	0.000143	0.00189	CcSEcCtD
Chloroquine—Asthenia—Mitoxantrone—multiple sclerosis	0.000141	0.00186	CcSEcCtD
Chloroquine—Anxiety—Dexamethasone—multiple sclerosis	0.00014	0.00185	CcSEcCtD
Chloroquine—Anxiety—Betamethasone—multiple sclerosis	0.00014	0.00185	CcSEcCtD
Chloroquine—Hypotension—Methylprednisolone—multiple sclerosis	0.000138	0.00183	CcSEcCtD
Chloroquine—Hepatitis—Methotrexate—multiple sclerosis	0.000138	0.00182	CcSEcCtD
Chloroquine—Vision blurred—Prednisone—multiple sclerosis	0.000135	0.00179	CcSEcCtD
Chloroquine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000134	0.00178	CcSEcCtD
Chloroquine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000134	0.00178	CcSEcCtD
Chloroquine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000134	0.00178	CcSEcCtD
Chloroquine—Insomnia—Triamcinolone—multiple sclerosis	0.000134	0.00177	CcSEcCtD
Chloroquine—Insomnia—Methylprednisolone—multiple sclerosis	0.000134	0.00177	CcSEcCtD
Chloroquine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000133	0.00176	CcSEcCtD
Chloroquine—Visual impairment—Methotrexate—multiple sclerosis	0.000133	0.00176	CcSEcCtD
Chloroquine—Agitation—Prednisone—multiple sclerosis	0.000132	0.00174	CcSEcCtD
Chloroquine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000132	0.00174	CcSEcCtD
Chloroquine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000132	0.00174	CcSEcCtD
Chloroquine—Angioedema—Prednisone—multiple sclerosis	0.000131	0.00173	CcSEcCtD
Chloroquine—Erythema multiforme—Methotrexate—multiple sclerosis	0.00013	0.00172	CcSEcCtD
Chloroquine—Tinnitus—Methotrexate—multiple sclerosis	0.000128	0.0017	CcSEcCtD
Chloroquine—Anorexia—Betamethasone—multiple sclerosis	0.000128	0.0017	CcSEcCtD
Chloroquine—Anorexia—Dexamethasone—multiple sclerosis	0.000128	0.0017	CcSEcCtD
Chloroquine—Urticaria—Prednisolone—multiple sclerosis	0.000128	0.00169	CcSEcCtD
Chloroquine—Hypotension—Dexamethasone—multiple sclerosis	0.000126	0.00166	CcSEcCtD
Chloroquine—Hypotension—Betamethasone—multiple sclerosis	0.000126	0.00166	CcSEcCtD
Chloroquine—Vomiting—Mitoxantrone—multiple sclerosis	0.000125	0.00165	CcSEcCtD
Chloroquine—Convulsion—Prednisone—multiple sclerosis	0.000124	0.00165	CcSEcCtD
Chloroquine—Rash—Mitoxantrone—multiple sclerosis	0.000124	0.00164	CcSEcCtD
Chloroquine—Headache—Mitoxantrone—multiple sclerosis	0.000123	0.00163	CcSEcCtD
Chloroquine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000122	0.00162	CcSEcCtD
Chloroquine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000122	0.00161	CcSEcCtD
Chloroquine—Anxiety—Prednisone—multiple sclerosis	0.000122	0.00161	CcSEcCtD
Chloroquine—Alopecia—Methotrexate—multiple sclerosis	0.000122	0.00161	CcSEcCtD
Chloroquine—Insomnia—Dexamethasone—multiple sclerosis	0.000122	0.00161	CcSEcCtD
Chloroquine—Insomnia—Betamethasone—multiple sclerosis	0.000122	0.00161	CcSEcCtD
Chloroquine—Urticaria—Triamcinolone—multiple sclerosis	0.000118	0.00156	CcSEcCtD
Chloroquine—Urticaria—Methylprednisolone—multiple sclerosis	0.000117	0.00155	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000117	0.00155	CcSEcCtD
Chloroquine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000117	0.00155	CcSEcCtD
Chloroquine—Decreased appetite—Betamethasone—multiple sclerosis	0.000117	0.00155	CcSEcCtD
Chloroquine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000117	0.00155	CcSEcCtD
Chloroquine—Nausea—Mitoxantrone—multiple sclerosis	0.000117	0.00154	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000116	0.00154	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000116	0.00154	CcSEcCtD
Chloroquine—Vision blurred—Methotrexate—multiple sclerosis	0.000113	0.0015	CcSEcCtD
Chloroquine—Anorexia—Prednisone—multiple sclerosis	0.000112	0.00148	CcSEcCtD
Chloroquine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000111	0.00147	CcSEcCtD
Chloroquine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000111	0.00147	CcSEcCtD
Chloroquine—Urticaria—Betamethasone—multiple sclerosis	0.000107	0.00141	CcSEcCtD
Chloroquine—Urticaria—Dexamethasone—multiple sclerosis	0.000107	0.00141	CcSEcCtD
Chloroquine—Asthenia—Triamcinolone—multiple sclerosis	0.000106	0.00141	CcSEcCtD
Chloroquine—Abdominal pain—Betamethasone—multiple sclerosis	0.000106	0.00141	CcSEcCtD
Chloroquine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000106	0.00141	CcSEcCtD
Chloroquine—Asthenia—Methylprednisolone—multiple sclerosis	0.000106	0.0014	CcSEcCtD
Chloroquine—Insomnia—Prednisone—multiple sclerosis	0.000106	0.0014	CcSEcCtD
Chloroquine—Pruritus—Triamcinolone—multiple sclerosis	0.000105	0.00139	CcSEcCtD
Chloroquine—Pruritus—Methylprednisolone—multiple sclerosis	0.000105	0.00138	CcSEcCtD
Chloroquine—Convulsion—Methotrexate—multiple sclerosis	0.000104	0.00137	CcSEcCtD
Chloroquine—Decreased appetite—Prednisone—multiple sclerosis	0.000102	0.00135	CcSEcCtD
Chloroquine—Rash—Prednisolone—multiple sclerosis	0.000102	0.00134	CcSEcCtD
Chloroquine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000101	0.00134	CcSEcCtD
Chloroquine—Headache—Prednisolone—multiple sclerosis	0.000101	0.00134	CcSEcCtD
Chloroquine—Confusional state—Methotrexate—multiple sclerosis	9.87e-05	0.00131	CcSEcCtD
Chloroquine—Anaphylactic shock—Methotrexate—multiple sclerosis	9.78e-05	0.00129	CcSEcCtD
Chloroquine—Feeling abnormal—Prednisone—multiple sclerosis	9.65e-05	0.00128	CcSEcCtD
Chloroquine—Asthenia—Dexamethasone—multiple sclerosis	9.64e-05	0.00128	CcSEcCtD
Chloroquine—Asthenia—Betamethasone—multiple sclerosis	9.64e-05	0.00128	CcSEcCtD
Chloroquine—Thrombocytopenia—Methotrexate—multiple sclerosis	9.58e-05	0.00127	CcSEcCtD
Chloroquine—Nausea—Prednisolone—multiple sclerosis	9.57e-05	0.00127	CcSEcCtD
Chloroquine—Pruritus—Betamethasone—multiple sclerosis	9.51e-05	0.00126	CcSEcCtD
Chloroquine—Pruritus—Dexamethasone—multiple sclerosis	9.51e-05	0.00126	CcSEcCtD
Chloroquine—Vomiting—Triamcinolone—multiple sclerosis	9.42e-05	0.00125	CcSEcCtD
Chloroquine—Vomiting—Methylprednisolone—multiple sclerosis	9.4e-05	0.00124	CcSEcCtD
Chloroquine—Rash—Triamcinolone—multiple sclerosis	9.34e-05	0.00124	CcSEcCtD
Chloroquine—Anorexia—Methotrexate—multiple sclerosis	9.33e-05	0.00123	CcSEcCtD
Chloroquine—Rash—Methylprednisolone—multiple sclerosis	9.32e-05	0.00123	CcSEcCtD
Chloroquine—Urticaria—Prednisone—multiple sclerosis	9.3e-05	0.00123	CcSEcCtD
Chloroquine—Headache—Triamcinolone—multiple sclerosis	9.28e-05	0.00123	CcSEcCtD
Chloroquine—Headache—Methylprednisolone—multiple sclerosis	9.26e-05	0.00123	CcSEcCtD
Chloroquine—Abdominal pain—Prednisone—multiple sclerosis	9.25e-05	0.00122	CcSEcCtD
Chloroquine—Diarrhoea—Dexamethasone—multiple sclerosis	9.2e-05	0.00122	CcSEcCtD
Chloroquine—Diarrhoea—Betamethasone—multiple sclerosis	9.2e-05	0.00122	CcSEcCtD
Chloroquine—Hypotension—Methotrexate—multiple sclerosis	9.14e-05	0.00121	CcSEcCtD
Chloroquine—Insomnia—Methotrexate—multiple sclerosis	8.85e-05	0.00117	CcSEcCtD
Chloroquine—Nausea—Triamcinolone—multiple sclerosis	8.8e-05	0.00116	CcSEcCtD
Chloroquine—Nausea—Methylprednisolone—multiple sclerosis	8.78e-05	0.00116	CcSEcCtD
Chloroquine—Vomiting—Dexamethasone—multiple sclerosis	8.55e-05	0.00113	CcSEcCtD
Chloroquine—Vomiting—Betamethasone—multiple sclerosis	8.55e-05	0.00113	CcSEcCtD
Chloroquine—Decreased appetite—Methotrexate—multiple sclerosis	8.51e-05	0.00113	CcSEcCtD
Chloroquine—Rash—Betamethasone—multiple sclerosis	8.48e-05	0.00112	CcSEcCtD
Chloroquine—Rash—Dexamethasone—multiple sclerosis	8.48e-05	0.00112	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.45e-05	0.00112	CcSEcCtD
Chloroquine—Headache—Dexamethasone—multiple sclerosis	8.42e-05	0.00111	CcSEcCtD
Chloroquine—Headache—Betamethasone—multiple sclerosis	8.42e-05	0.00111	CcSEcCtD
Chloroquine—Asthenia—Prednisone—multiple sclerosis	8.4e-05	0.00111	CcSEcCtD
Chloroquine—Pruritus—Prednisone—multiple sclerosis	8.28e-05	0.0011	CcSEcCtD
Chloroquine—Feeling abnormal—Methotrexate—multiple sclerosis	8.06e-05	0.00107	CcSEcCtD
Chloroquine—Diarrhoea—Prednisone—multiple sclerosis	8.01e-05	0.00106	CcSEcCtD
Chloroquine—Nausea—Betamethasone—multiple sclerosis	7.98e-05	0.00106	CcSEcCtD
Chloroquine—Nausea—Dexamethasone—multiple sclerosis	7.98e-05	0.00106	CcSEcCtD
Chloroquine—Urticaria—Methotrexate—multiple sclerosis	7.77e-05	0.00103	CcSEcCtD
Chloroquine—Abdominal pain—Methotrexate—multiple sclerosis	7.73e-05	0.00102	CcSEcCtD
Chloroquine—Vomiting—Prednisone—multiple sclerosis	7.44e-05	0.000985	CcSEcCtD
Chloroquine—Rash—Prednisone—multiple sclerosis	7.38e-05	0.000977	CcSEcCtD
Chloroquine—Headache—Prednisone—multiple sclerosis	7.33e-05	0.000971	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL2—multiple sclerosis	7.09e-05	0.000766	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TNFAIP3—multiple sclerosis	7.03e-05	0.000759	CbGpPWpGaD
Chloroquine—Asthenia—Methotrexate—multiple sclerosis	7.02e-05	0.000929	CcSEcCtD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.01e-05	0.000758	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.99e-05	0.000755	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—TLR4—multiple sclerosis	6.96e-05	0.000752	CbGpPWpGaD
Chloroquine—Nausea—Prednisone—multiple sclerosis	6.95e-05	0.00092	CcSEcCtD
Chloroquine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.94e-05	0.00075	CbGpPWpGaD
Chloroquine—Pruritus—Methotrexate—multiple sclerosis	6.92e-05	0.000916	CcSEcCtD
Chloroquine—TNF—TWEAK Signaling Pathway—IL6—multiple sclerosis	6.91e-05	0.000747	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—RRM1—multiple sclerosis	6.82e-05	0.000738	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—GPR65—multiple sclerosis	6.81e-05	0.000736	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—CCL2—multiple sclerosis	6.81e-05	0.000736	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.75e-05	0.000729	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	6.73e-05	0.000728	CbGpPWpGaD
Chloroquine—Diarrhoea—Methotrexate—multiple sclerosis	6.69e-05	0.000886	CcSEcCtD
Chloroquine—TNF—MAPK Signaling Pathway—FAS—multiple sclerosis	6.65e-05	0.000719	CbGpPWpGaD
Chloroquine—TNF—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	6.57e-05	0.00071	CbGpPWpGaD
Chloroquine—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.56e-05	0.000709	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IL1B—multiple sclerosis	6.53e-05	0.000706	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CD80—multiple sclerosis	6.42e-05	0.000694	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD28—multiple sclerosis	6.32e-05	0.000683	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.3e-05	0.000681	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—MAPK1—multiple sclerosis	6.26e-05	0.000677	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL13—multiple sclerosis	6.23e-05	0.000673	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR1—multiple sclerosis	6.23e-05	0.000673	CbGpPWpGaD
Chloroquine—Vomiting—Methotrexate—multiple sclerosis	6.22e-05	0.000823	CcSEcCtD
Chloroquine—TLR9—Immune System—CCR2—multiple sclerosis	6.21e-05	0.000671	CbGpPWpGaD
Chloroquine—TLR9—Immune System—PTPRC—multiple sclerosis	6.21e-05	0.000671	CbGpPWpGaD
Chloroquine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.18e-05	0.000668	CbGpPWpGaD
Chloroquine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.18e-05	0.000668	CbGpPWpGaD
Chloroquine—Rash—Methotrexate—multiple sclerosis	6.17e-05	0.000817	CcSEcCtD
Chloroquine—Headache—Methotrexate—multiple sclerosis	6.13e-05	0.000811	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—TLR4—multiple sclerosis	6.12e-05	0.000662	CbGpPWpGaD
Chloroquine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.09e-05	0.000659	CbGpPWpGaD
Chloroquine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.09e-05	0.000659	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.07e-05	0.000656	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.02e-05	0.000651	CbGpPWpGaD
Chloroquine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.01e-05	0.00065	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6e-05	0.000649	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-DPB1—multiple sclerosis	6e-05	0.000648	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6e-05	0.000648	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	5.95e-05	0.000643	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	5.95e-05	0.000643	CbGpPWpGaD
Chloroquine—TNF—Vitamin B12 Metabolism—IL6—multiple sclerosis	5.91e-05	0.000639	CbGpPWpGaD
Chloroquine—Nausea—Methotrexate—multiple sclerosis	5.81e-05	0.000769	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	5.8e-05	0.000627	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IFNG—multiple sclerosis	5.79e-05	0.000626	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	5.79e-05	0.000625	CbGpPWpGaD
Chloroquine—TLR9—Immune System—ITGA4—multiple sclerosis	5.77e-05	0.000624	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD40—multiple sclerosis	5.77e-05	0.000624	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFNB1—multiple sclerosis	5.73e-05	0.000619	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CTLA4—multiple sclerosis	5.69e-05	0.000615	CbGpPWpGaD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—multiple sclerosis	5.68e-05	0.000614	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	5.66e-05	0.000611	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—PRNP—multiple sclerosis	5.65e-05	0.000611	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CD80—multiple sclerosis	5.65e-05	0.00061	CbGpPWpGaD
Chloroquine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	5.64e-05	0.00061	CbGpPWpGaD
Chloroquine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.63e-05	0.000608	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—TGFB1—multiple sclerosis	5.53e-05	0.000598	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—MAPK1—multiple sclerosis	5.42e-05	0.000586	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.33e-05	0.000576	CbGpPWpGaD
Chloroquine—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.32e-05	0.000575	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.3e-05	0.000573	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—MYC—multiple sclerosis	5.28e-05	0.00057	CbGpPWpGaD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—multiple sclerosis	5.27e-05	0.000569	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.24e-05	0.000567	CbGpPWpGaD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—multiple sclerosis	5.16e-05	0.000558	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL1B—multiple sclerosis	5.16e-05	0.000558	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL2—multiple sclerosis	5.14e-05	0.000556	CbGpPWpGaD
Chloroquine—TLR9—Immune System—VCAM1—multiple sclerosis	5.02e-05	0.000543	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-DQA1—multiple sclerosis	5.01e-05	0.000541	CbGpPWpGaD
Chloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.94e-05	0.000534	CbGpPWpGaD
Chloroquine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.88e-05	0.000527	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—MMP9—multiple sclerosis	4.87e-05	0.000526	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.82e-05	0.000521	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.82e-05	0.000521	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IL6—multiple sclerosis	4.81e-05	0.00052	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—MAPK1—multiple sclerosis	4.8e-05	0.000519	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	4.79e-05	0.000518	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—TYK2—multiple sclerosis	4.77e-05	0.000515	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.69e-05	0.000507	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-DQB1—multiple sclerosis	4.68e-05	0.000506	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.68e-05	0.000506	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.59e-05	0.000496	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	4.53e-05	0.000489	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD86—multiple sclerosis	4.51e-05	0.000487	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL3—multiple sclerosis	4.44e-05	0.00048	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.42e-05	0.000478	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD40LG—multiple sclerosis	4.42e-05	0.000478	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.42e-05	0.000478	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.42e-05	0.000478	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	4.42e-05	0.000478	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—PTPRC—multiple sclerosis	4.39e-05	0.000475	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD8A—multiple sclerosis	4.37e-05	0.000473	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.37e-05	0.000472	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.37e-05	0.000472	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CD4—multiple sclerosis	4.31e-05	0.000466	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PTGER4—multiple sclerosis	4.27e-05	0.000462	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-B—multiple sclerosis	4.21e-05	0.000455	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PGR—multiple sclerosis	4.21e-05	0.000455	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.13e-05	0.000446	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCR3—multiple sclerosis	4.13e-05	0.000446	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CD28—multiple sclerosis	4.09e-05	0.000442	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—MYC—multiple sclerosis	4.02e-05	0.000435	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR2—multiple sclerosis	4.01e-05	0.000434	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—TGFB1—multiple sclerosis	4.01e-05	0.000434	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—STAT3—multiple sclerosis	4.01e-05	0.000433	CbGpPWpGaD
Chloroquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4e-05	0.000433	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL2RA—multiple sclerosis	3.94e-05	0.000426	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.94e-05	0.000426	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—MAPK1—multiple sclerosis	3.93e-05	0.000425	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—BCHE—multiple sclerosis	3.92e-05	0.000424	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-A—multiple sclerosis	3.9e-05	0.000421	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—IL1B—multiple sclerosis	3.89e-05	0.000421	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.83e-05	0.000414	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IL6—multiple sclerosis	3.82e-05	0.000413	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—TGFB1—multiple sclerosis	3.71e-05	0.000401	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CNR1—multiple sclerosis	3.7e-05	0.0004	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—IL6—multiple sclerosis	3.69e-05	0.000399	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TLR4—multiple sclerosis	3.56e-05	0.000385	CbGpPWpGaD
Chloroquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.56e-05	0.000385	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-DRB1—multiple sclerosis	3.56e-05	0.000385	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.5e-05	0.000378	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	3.45e-05	0.000373	CbGpPWpGaD
Chloroquine—TLR9—Immune System—ICAM1—multiple sclerosis	3.42e-05	0.000369	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	3.4e-05	0.000367	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL10—multiple sclerosis	3.33e-05	0.00036	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD80—multiple sclerosis	3.29e-05	0.000356	CbGpPWpGaD
Chloroquine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.23e-05	0.000349	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—SRM—multiple sclerosis	3.23e-05	0.000349	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.12e-05	0.000337	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.11e-05	0.000336	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.07e-05	0.000332	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—SRM—multiple sclerosis	3.05e-05	0.000329	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—MAPK1—multiple sclerosis	3.04e-05	0.000328	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—MYC—multiple sclerosis	3.03e-05	0.000328	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—TGFB1—multiple sclerosis	3.02e-05	0.000327	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL6—multiple sclerosis	3.02e-05	0.000327	CbGpPWpGaD
Chloroquine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.99e-05	0.000323	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.99e-05	0.000323	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—MAPK1—multiple sclerosis	2.97e-05	0.000321	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CD86—multiple sclerosis	2.92e-05	0.000315	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL5—multiple sclerosis	2.87e-05	0.00031	CbGpPWpGaD
Chloroquine—CYP1A1—Biological oxidations—POMC—multiple sclerosis	2.82e-05	0.000305	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—IL6—multiple sclerosis	2.8e-05	0.000302	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—SRM—multiple sclerosis	2.79e-05	0.000302	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TYK2—multiple sclerosis	2.78e-05	0.0003	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.74e-05	0.000296	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.73e-05	0.000295	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.68e-05	0.000289	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SPP1—multiple sclerosis	2.66e-05	0.000287	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	2.65e-05	0.000287	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.63e-05	0.000284	CbGpPWpGaD
Chloroquine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.62e-05	0.000283	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFNG—multiple sclerosis	2.6e-05	0.000281	CbGpPWpGaD
Chloroquine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.59e-05	0.00028	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR5—multiple sclerosis	2.59e-05	0.000279	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL2RA—multiple sclerosis	2.55e-05	0.000275	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD4—multiple sclerosis	2.51e-05	0.000271	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—SRM—multiple sclerosis	2.43e-05	0.000263	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.42e-05	0.000262	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.42e-05	0.000261	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.36e-05	0.000255	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—APOE—multiple sclerosis	2.36e-05	0.000255	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—APOE—multiple sclerosis	2.35e-05	0.000254	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—IL6—multiple sclerosis	2.33e-05	0.000252	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL1B—multiple sclerosis	2.32e-05	0.000251	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL2—multiple sclerosis	2.31e-05	0.00025	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.29e-05	0.000248	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.27e-05	0.000246	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.27e-05	0.000246	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.26e-05	0.000245	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.15e-05	0.000232	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.15e-05	0.000232	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CD80—multiple sclerosis	2.13e-05	0.00023	CbGpPWpGaD
Chloroquine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.13e-05	0.00023	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.1e-05	0.000227	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.09e-05	0.000225	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.08e-05	0.000225	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—POMC—multiple sclerosis	2.03e-05	0.000219	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—POMC—multiple sclerosis	2.02e-05	0.000218	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL2—multiple sclerosis	1.98e-05	0.000214	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.97e-05	0.000213	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.97e-05	0.000213	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—TYK2—multiple sclerosis	1.97e-05	0.000212	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GPC5—multiple sclerosis	1.96e-05	0.000212	CbGpPWpGaD
Chloroquine—TLR9—Immune System—STAT3—multiple sclerosis	1.94e-05	0.00021	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.92e-05	0.000208	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—ALB—multiple sclerosis	1.85e-05	0.0002	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.8e-05	0.000195	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TYK2—multiple sclerosis	1.8e-05	0.000194	CbGpPWpGaD
Chloroquine—TLR9—Immune System—MAPK1—multiple sclerosis	1.77e-05	0.000191	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.72e-05	0.000186	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.72e-05	0.000185	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.72e-05	0.000185	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000176	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.62e-05	0.000175	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.62e-05	0.000175	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.00017	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—MMP9—multiple sclerosis	1.55e-05	0.000167	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.5e-05	0.000162	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL2—multiple sclerosis	1.49e-05	0.000161	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.49e-05	0.000161	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.48e-05	0.00016	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MMP9—multiple sclerosis	1.41e-05	0.000153	CbGpPWpGaD
Chloroquine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.39e-05	0.00015	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—STAT3—multiple sclerosis	1.38e-05	0.000149	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL6—multiple sclerosis	1.36e-05	0.000147	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.00014	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—TGFB1—multiple sclerosis	1.28e-05	0.000138	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.26e-05	0.000136	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—STAT3—multiple sclerosis	1.26e-05	0.000136	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—MAPK1—multiple sclerosis	1.25e-05	0.000135	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.22e-05	0.000132	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.2e-05	0.00013	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.2e-05	0.000129	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.17e-05	0.000127	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MYC—multiple sclerosis	1.17e-05	0.000126	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TGFB1—multiple sclerosis	1.17e-05	0.000126	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.16e-05	0.000125	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MAPK1—multiple sclerosis	1.14e-05	0.000124	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.12e-05	0.000121	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000117	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.06e-05	0.000114	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.06e-05	0.000114	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.94e-06	0.000107	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—BCHE—multiple sclerosis	9.89e-06	0.000107	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.89e-06	0.000107	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GPC5—multiple sclerosis	9.67e-06	0.000104	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—IL6—multiple sclerosis	9.62e-06	0.000104	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—BCHE—multiple sclerosis	9.35e-06	0.000101	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.07e-06	9.8e-05	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL6—multiple sclerosis	8.78e-06	9.49e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—BCHE—multiple sclerosis	8.57e-06	9.26e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.01e-06	8.66e-05	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.51e-06	8.12e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—BCHE—multiple sclerosis	7.47e-06	8.07e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.04e-06	7.6e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—APOE—multiple sclerosis	5.95e-06	6.43e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—APOE—multiple sclerosis	5.62e-06	6.08e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—APOE—multiple sclerosis	5.16e-06	5.57e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—POMC—multiple sclerosis	5.11e-06	5.53e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—POMC—multiple sclerosis	4.83e-06	5.22e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ALB—multiple sclerosis	4.66e-06	5.04e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.6e-06	4.97e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—APOE—multiple sclerosis	4.49e-06	4.85e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—POMC—multiple sclerosis	4.43e-06	4.79e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ALB—multiple sclerosis	4.4e-06	4.76e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.23e-06	4.57e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ALB—multiple sclerosis	4.04e-06	4.36e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—POMC—multiple sclerosis	3.86e-06	4.17e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—POMC—multiple sclerosis	3.64e-06	3.93e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ALB—multiple sclerosis	3.52e-06	3.8e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.31e-06	3.58e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.77e-06	2.99e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.38e-06	2.57e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.17e-06	2.34e-05	CbGpPWpGaD
